HERCULES, Calif.—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that AOAC INTERNATIONAL and AFNOR have approved the CFX Opus Deepwell Real-Time PCR System for use with Bio-Rad iQ-Check Real-Time PCR Kits.
AOAC INTERNATIONAL has approved the thermal cycler for use with all iQ-Check kits. To obtain approval, a validation study was performed, as part of the AOAC Performance Tested Methods Program, that demonstrated no differences in results between the iQ-Check and reference methods.
AFNOR has approved the instrument for use with the iQ-Check Salmonella spp., Listeria spp., L. monocytogenes, E. coli O157:H7 and Cronobacter spp. PCR Kits. The validation follows the ISO 16140-2:2016 standard and AFNOR technical rules.
The CFX Opus Deepwell Real-Time PCR System offers a modern user experience with flexible connectivity options, high-performance thermal uniformity, and cloud connection capabilities while maintaining the same performance standards customers have come to trust. The certificates are available at www.bio-rad.com/validations.
For more information on Bio-Rad’s complete range of iQ-Check real-time PCR test kits, please visit: www.bio-rad.com/iqcheck.
BIO-RAD is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,300 employees worldwide and $2.8 billion in revenues in 2022. For more information, please visit bio-rad.com.
Media Contacts:
Bio-Rad Laboratories, Inc.
Wendy Lauer
510-741-5653
wendy_lauer@bio-rad.com
CG Life
Isabella Rodriguez
708-833-1572
irodriguez@cglife.com